T-CELL LYMPHOBLASTIC LYMPHOMA
Clinical trials for T-CELL LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could adding bortezomib boost chemo for young blood cancer patients?
Disease control OngoingThis study tests whether adding the drug bortezomib to standard chemotherapy helps children and young adults (ages 1 to 30) with newly diagnosed T-cell acute lymphoblastic leukemia or T-cell lymphoblastic lymphoma. About 847 participants received either standard chemo alone or ch…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 31, 2026 00:00 UTC
-
Adult leukemia patients get Kid-Style chemo combo in new trial
Disease control OngoingThis phase 2 trial is testing whether a combination of chemotherapy drugs typically used in children can be safe and effective for adults aged 18 to 60 with newly diagnosed Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL). The study aims to see if this 'pediatr…
Matched conditions: T-CELL LYMPHOBLASTIC LYMPHOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 18:20 UTC